Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Regulation of XPO5 phosphorylation by PP2A in hepatocellular carcinoma

View through CrossRef
AbstractExportin 5 (XPO5) is a shuttle protein that mediates precursor miRNA (pre‐miRNA) export from the nucleus to the cytoplasm, an important step in miRNA maturation. We previously demonstrated that XPO5 was phosphorylated by ERK kinase and subsequently underwent conformation change by the peptidyl‐prolyl isomerase Pin1, leading to the reduced miRNA expression in hepatocellular carcinoma (HCC). Protein phosphorylation modification serves as a reversible regulatory mechanism precisely governed by protein kinases and phosphatases. Here we identified that the phosphatase PP2A catalyzed XPO5 dephosphorylation. PP2A holoenzyme is a ternary complex composed of a catalytic subunit, a scaffold subunit, and a regulatory subunit that determines substrate specificity. In this study, we characterized the involvement of B55β subunit in XPO5 dephosphorylation that favored the distribution of XPO5 into the cytoplasm and promoted miRNA expression, leading to HCC inhibition in vitro and in vivo. Our study demonstrates the regulatory role of B55β‐containing PP2A in miRNA expression and may shed light on HCC pathogenesis.
Title: Regulation of XPO5 phosphorylation by PP2A in hepatocellular carcinoma
Description:
AbstractExportin 5 (XPO5) is a shuttle protein that mediates precursor miRNA (pre‐miRNA) export from the nucleus to the cytoplasm, an important step in miRNA maturation.
We previously demonstrated that XPO5 was phosphorylated by ERK kinase and subsequently underwent conformation change by the peptidyl‐prolyl isomerase Pin1, leading to the reduced miRNA expression in hepatocellular carcinoma (HCC).
Protein phosphorylation modification serves as a reversible regulatory mechanism precisely governed by protein kinases and phosphatases.
Here we identified that the phosphatase PP2A catalyzed XPO5 dephosphorylation.
PP2A holoenzyme is a ternary complex composed of a catalytic subunit, a scaffold subunit, and a regulatory subunit that determines substrate specificity.
In this study, we characterized the involvement of B55β subunit in XPO5 dephosphorylation that favored the distribution of XPO5 into the cytoplasm and promoted miRNA expression, leading to HCC inhibition in vitro and in vivo.
Our study demonstrates the regulatory role of B55β‐containing PP2A in miRNA expression and may shed light on HCC pathogenesis.

Related Results

Abstract 2325: Identification of RACK1 as a novel regulatory subunit of PP2A.
Abstract 2325: Identification of RACK1 as a novel regulatory subunit of PP2A.
Abstract Protein Phosphatase 2A (PP2A) is a major serine/threonine phosphatase in cells. It consists of a catalytic (C), structural (A) and regulatory/variable B-typ...
Abstract 5287: Identification of metadherin in a complex with RACK1/PP2A in mammary epithelial cells
Abstract 5287: Identification of metadherin in a complex with RACK1/PP2A in mammary epithelial cells
Abstract Protein Phosphatase 2A (PP2A) is a major serine/threonine phosphatase in cells. It consists of a catalytic (C), structural (A) and regulatory/variable B-typ...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract Introduction Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
PP2A: The Wolf in Sheep’s Clothing?
PP2A: The Wolf in Sheep’s Clothing?
Protein Phosphatase 2A (PP2A) is a major serine/threonine phosphatase in cells. It consists of a catalytic subunit (C), a structural subunit (A), and a regulatory/variable B-type ...
The Key Role of the Phosphatase PP2A in the Development of Acute Myeloid Leukemia
The Key Role of the Phosphatase PP2A in the Development of Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a heterogeneous malignant disorder of hematopoietic progenitor cells characterized by the accumulation of several genetic and epigenetic mutations. ...
Abstract 7273: Small molecule activation of PP2A in the treatment of melanoma
Abstract 7273: Small molecule activation of PP2A in the treatment of melanoma
Abstract Protein phosphatase 2A (PP2A) is a heterotrimeric holoenzyme functioning as a serine/threonine phosphatase, where it accounts for about 50-70% of all serine...
Genistein Decreases APP/tau Phosphorylation and Ameliorates Aβ Overproduction Through Inhibiting CIP2A
Genistein Decreases APP/tau Phosphorylation and Ameliorates Aβ Overproduction Through Inhibiting CIP2A
Background: Upregulation of Cancerous Inhibitor of PP2A (CIP2A) plays an important role in disease-related phosphorylation of tau/APP and tau pathology/Aβ overproduction through in...
Insight into the impact of diabetes mellitus on the increased risk of hepatocellular carcinoma: mini-review
Insight into the impact of diabetes mellitus on the increased risk of hepatocellular carcinoma: mini-review
AbstractHepatocellular carcinoma is a multifactorial disease which is associated with a background of many causal risk factors. Diabetes mellitus however is one of the most common ...

Back to Top